Company profile

ENTA stock data

(
)

Calendar

25 Nov 20
1 Dec 20
30 Sep 21

News

Quarter (USD) Jun 20 Mar 20 Dec 19 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Sep 20 Sep 19 Sep 18 Sep 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
20 Nov 20 Luly Jay R. Common Stock Grant Aquire A No 0 26,500 0 676,189
20 Nov 20 Luly Jay R. Stock Option Common Stock Grant Aquire A No 43.57 107,800 4.7M 107,800
20 Nov 20 Mellett Paul J Common Stock Grant Aquire A No 0 7,600 0 53,904
20 Nov 20 Mellett Paul J Stock Option Common Stock Grant Aquire A No 43.57 30,800 1.34M 30,800
20 Nov 20 Yat Sun Or Common Stock Grant Aquire A No 0 7,600 0 313,515
20 Nov 20 Yat Sun Or Stock Option Common Stock Grant Aquire A No 43.57 30,800 1.34M 30,800
20 Nov 20 Nathalie Adda Common Stock Grant Aquire A No 0 7,600 0 23,234
20 Nov 20 Nathalie Adda Stock Option Common Stock Grant Aquire A No 43.57 30,800 1.34M 30,800
20 Nov 20 Gardiner Nathaniel S. Common Stock Grant Aquire A No 0 7,600 0 36,871
20 Nov 20 Gardiner Nathaniel S. Stock Option Common Stock Grant Aquire A No 43.57 30,800 1.34M 30,800
92.8% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 167 179 -6.7%
Opened positions 15 38 -60.5%
Closed positions 27 14 +92.9%
Increased positions 76 64 +18.8%
Reduced positions 53 52 +1.9%
13F shares
Current Prev Q Change
Total value 1.07B 2.09B -48.6%
Total shares 18.62M 18.1M +2.9%
Total puts 53.28K 56.4K -5.5%
Total calls 0 32.5K EXIT
Total put/call ratio Infinity 1.7 +Infinity%
Largest owners
Shares Value Change
BLK Blackrock 3.22M $147.21M +6.1%
Farallon Capital Management 1.78M $81.26M +1.4%
Vanguard 1.72M $78.78M +1.8%
Renaissance Technologies 1.03M $47.11M +9.1%
TROW T. Rowe Price 974.43K $44.61M -24.0%
STT State Street 963.52K $44.11M -9.0%
Krensavage Asset Management 825.33K $37.78M +8.2%
Dimensional Fund Advisors 700.01K $32.05M -2.3%
AMP Ameriprise Financial 607.57K $27.82M +8.8%
IVZ Invesco 535.22K $24.5M +361.8%
Largest transactions
Shares Bought/sold Change
IVZ Invesco 535.22K +419.31K +361.8%
TROW T. Rowe Price 974.43K -308.13K -24.0%
Armistice Capital 524K +200K +61.7%
BLK Blackrock 3.22M +185.22K +6.1%
DB Deutsche Bank 11.66K -130.4K -91.8%
Marshall Wace 34.93K -96.89K -73.5%
STT State Street 963.52K -95.58K -9.0%
Millennium Management 125.91K +89.03K +241.3%
Assenagon Asset Management 136.2K +87.38K +179.0%
Renaissance Technologies 1.03M +86.1K +9.1%

Financial report summary

?
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: accretion, Afimmune, Aid, Akcea, AngioLab, apparent, argued, Asian, AstraZeneca, Atea, border, borrow, borrowing, Boston, briefly, capacity, Circuit, Cosunter, CRL, diagnostic, distancing, doctor, dramatically, driver, Eli, environment, estate, exacerbated, expedient, fill, Foletta, Fujian, Gardiner, GDPR, hematopoietic, hepatoprotective, HighTide, hMPV, home, incremental, inside, intake, Kowa, leveraging, Lilly, mask, masked, missed, Mitsubishi, mix, moved, MYR, nanomolar, Nathaniel, Northern, NuSirt, outbreak, pandemic, pattern, pause, paused, peripheral, Pharma, PharmaKing, prioritize, Qilu, reactivating, real, reconsider, refile, region, Relief, remanded, renewal, rest, resume, ROU, routine, RSU, RSVTx, SA, Sagimet, shipment, spread, staying, subset, TaiwanJ, Tanabe, tract, turnover, undesignated, undisclosed, unissued, upcoming, upper, vacated, winter, workforce, Wuhan, Zhimeng
Removed: absorb, Alberio, Allergan, allocation, amortized, Bank, BESP, biliary, Boehringer, calling, carboxylic, cholestatic, Codification, collectibility, constitutionality, contemplated, copy, counseled, customer, DC, deliverable, destroyed, differentiated, digest, digestive, diversify, evidenced, ExhibitNumber, expired, FiledHerewith, forfeiture, fulfilled, function, Genfit, GlaxoSmithKline, glycine, gradual, HV, Ingelheim, leasing, licensor, lifestyle, marketplace, Maxwell, measurable, men, modification, monitored, NE, obese, obeticholic, occupancy, persuasive, PK, PN, presumptive, promptly, Pulmocide, reconciling, reliably, rendered, rent, Room, satisfying, scar, separated, simulation, slowly, Spring, steroidal, taurine, tenant, tissue, Tobira, TPE, transact, Transgene, transplantation, upheld, validating, volunteer, women